Zim Laboratories Ltd

NSE: ZIMLAB · BSE: 541400 · Pharmaceuticals & Biotechnology · 33 announcements

Share price: ₹146.00
Market cap: ₹783.4 Cr
Revenue (annual): ₹374.4 Cr
Net profit (annual): ₹5.84 Cr
P/E (TTM): 212.0×Sector 47.4×
Promoter holding: 30.36%+0.01% QoQ
FII holding: 0.03%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Employee Stock Options 6 Merger & Restructuring 5 Annual General Meeting 5 Earnings Call 4 Financial Results 3 Promoter Buying (Off-Market) 2 Board Meeting Date 2 Regulatory Approval 1 Other Announcement 1 Management Change 1 Business Update 1 Annual Report 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

19 May 2026 16:44 IST NSE

Management Change

Zim Laboratories Management Change

Zim Laboratories appointed M/s Dhananjay V. Joshi & Associates as Cost Auditor for FY 2026-27. This ensures regulatory compliance and oversight for the upcoming fiscal year.

Execution: F.Y. 2026-27

Read the filing ↗